D.A. Davidson & Co. Pacira Bio Sciences, Inc. Transaction History

D.A. Davidson & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 04, 2018	SELL	$29.98 - $46.35 $407,488 - $629,989	-13,592 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$31.85 - $46.95 $27,518 - $40,564	864 Added 6.79%	13,592 $620,000
Q3 2017 Nov 08, 2017	SELL	$35.7 - $39.5 $4,748 - $5,253	-133 Reduced 1.03%	12,728 $477,000
Q2 2017 Aug 11, 2017	BUY	N/A	12,861	12,861 $0

302

51.6M

378K

1.53M

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $712M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.